BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1531856)

  • 21. [Gammadynamic treatment in advanced malignant tumors].
    Bloznelyte-Plesniene L; Stancius A
    Medicina (Kaunas); 2002; 38(2):186-9. PubMed ID: 12474738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action spectra for hematoporphyrin derivative and Photofrin II with respect to sensitization of human cells in vitro to photoinactivation.
    Moan J; Sommer S
    Photochem Photobiol; 1984 Nov; 40(5):631-4. PubMed ID: 6240066
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental study on the killing effect of hematoporphyrin derivative-laser to transplanted tumor in animals].
    Lu ZD
    Zhonghua Yi Xue Za Zhi; 1983 Jun; 63(6):326-9. PubMed ID: 6226342
    [No Abstract]   [Full Text] [Related]  

  • 24. Some components of the tumor-localizing fraction of hematoporphyrin derivative.
    Ho YK; Pandey RK; Missert JR; Dougherty TJ
    Photochem Photobiol; 1990 Dec; 52(6):1085-8. PubMed ID: 2150886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phototherapy of tumors using photosensitizing agents].
    Gamalev NF; Mikhalkin IA
    Eksp Onkol; 1988; 10(1):9-16. PubMed ID: 2967173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity and physicochemical properties of Photofrin.
    Ho YK; Missert JR; Dougherty TJ
    Photochem Photobiol; 1991 Jul; 54(1):83-7. PubMed ID: 1835101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light dosimetry model for photodynamic therapy treatment planning.
    Grossweiner LI
    Lasers Surg Med; 1991; 11(2):165-73. PubMed ID: 1827855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laser therapy--things to come: multiple spectra and photodynamic therapy.
    Wood JW
    Am J Gastroenterol; 1985 Sep; 80(9):732-3. PubMed ID: 2931020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues.
    Wharen RE; Anderson RE; Laws ER
    Neurosurgery; 1983 Apr; 12(4):446-50. PubMed ID: 6222266
    [No Abstract]   [Full Text] [Related]  

  • 30. [The relationship between transport site of HPD and photodamage region of human gastric cancer cells in the cell cycle].
    Wang DS; Liang YY
    Shi Yan Sheng Wu Xue Bao; 1988 Mar; 21(1):35-45. PubMed ID: 2849266
    [No Abstract]   [Full Text] [Related]  

  • 31. Relation between polyporphyrin distribution and blood brain barrier changes in the rat glioma model.
    Ji Y; Walstad DL; Brown JT; Powers SK
    Lasers Surg Med; 1992; 12(2):174-9. PubMed ID: 1533436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photoinduced degradation and modification of Photofrin II in cells in vitro.
    Moan J; Rimington C; Malik Z
    Photochem Photobiol; 1988 Mar; 47(3):363-7. PubMed ID: 2967980
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thermal effects of argon laser and hematoporphyrin derivatives on subcutaneous tumor tissue in mice].
    Hsu HY; Hau DM; Chang H
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Jun; 3(6):377-82. PubMed ID: 2968462
    [No Abstract]   [Full Text] [Related]  

  • 34. [Electron microscopic observations on the killing effect of hematoporphyrin derivative-laser to S180 tumor cells].
    Lu ZD
    Zhonghua Yi Xue Za Zhi; 1983 Jun; 63(6):336-8. PubMed ID: 6226344
    [No Abstract]   [Full Text] [Related]  

  • 35. Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma.
    Tse DT; Dutton JJ; Weingeist TA; Hermsen VM; Kersten RC
    Arch Ophthalmol; 1984 Jun; 102(6):833-8. PubMed ID: 6233958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy for completely obstructing esophageal carcinoma.
    Likier HM; Levine JG; Lightdale CJ
    Gastrointest Endosc; 1991; 37(1):75-8. PubMed ID: 1706287
    [No Abstract]   [Full Text] [Related]  

  • 37. Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report.
    Tse DT; Kersten RC; Anderson RL
    Arch Ophthalmol; 1984 Jul; 102(7):990-4. PubMed ID: 6234868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanomas.
    Bruce RA
    Lasers Surg Med; 1984; 4(1):59-64. PubMed ID: 6235417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposure (dose) tables for hematoporphyrin derivative photoradiation therapy.
    Berns MW; Berns GS; Coffey J; Wile AG
    Lasers Surg Med; 1984; 4(1):107-31. PubMed ID: 6235411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The photodynamic effects of photofrin II, hematoporphyrin derivative, hematoporphyrin, and tetrasodium-mesotetra(4-sulfonatophenyl)porphine in vitro: clonogenic cell survival and drug uptake studies.
    West CM; Moore JV
    Photochem Photobiol; 1989 Feb; 49(2):169-74. PubMed ID: 2523543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.